Company: PFSA
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112723
Chunk: 13

Company: Profusa, Inc.
Filing Date: 2025-11-19
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
2025, the Company no longer meets Nasdaq
Listing Rule 5450(a)(1), which requires companies listed on the Nasdaq Global Market to maintain a minimum bid price of $1.00 per share.
The Company has been provided a compliance period of 180 calendar days, or until March 10, 2026, to regain compliance with Nasdaq Listing
Rule 5450(a)(1). If at any time during this compliance period, the Common Stock has a closing bid price bid price of at least $1.00 per
share for a minimum of ten consecutive business days, Nasdaq will provide the Company with written confirmation of compliance and this
matter will be closed, provided, however that Nasdaq may, in its discretion, require the Company to maintain the minimum bid price for
a period in excess of ten consecutive business days, but generally no more than 20 consecutive business days, before determining that
the Company has demonstrated an ability to maintain long-term compliance.

In the event the Company does not regain compliance with Nasdaq
Listing Rule 5450(a)(1) prior to the expiration of the compliance period, then Nasdaq may grant the Company a second 180 calendar
day period to regain compliance, provided, among other things, the Company meets the continued listing requirement for market value
of publicly-held shares and all other initial listing standards for The Nasdaq Global Market, other than the minimum bid price
requirement, and notifies Nasdaq of its intent to cure the deficiency. If the Company does not regain compliance within the allotted
compliance periods, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Common Stock will be
subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel. The Company is
monitoring the minimum bid price of its listed securities and is considering available options to regain compliance with
Nasdaq’s continued listing standards. There can be no assurance that the Company will be able to regain compliance with Nasdaq
Listing Rule 5450(a)(1) or maintain compliance with other applicable Nasdaq listing requirements.

Significant Risks and Uncertainties

The Company operates in a dynamic and highly competitive industry and
believes that changes in any of the following areas could have a material adverse effect on the Company’s future financial position,
results of operations, or cash flows: ability to obtain future financing; advances and trends in new technologies and industry standards;
results of clinical trials; regulatory